nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP3A4—Rivastigmine—Alzheimer's disease	0.155	0.432	CbGbCtD
Ethosuximide—CYP3A4—Donepezil—Alzheimer's disease	0.124	0.345	CbGbCtD
Ethosuximide—CYP3A4—Galantamine—Alzheimer's disease	0.08	0.223	CbGbCtD
Ethosuximide—Myopia—Memantine—Alzheimer's disease	0.0181	0.0363	CcSEcCtD
Ethosuximide—Libido increased—Galantamine—Alzheimer's disease	0.00923	0.0185	CcSEcCtD
Ethosuximide—Upset stomach—Galantamine—Alzheimer's disease	0.00857	0.0172	CcSEcCtD
Ethosuximide—Methyprylon—CYP2D6—Alzheimer's disease	0.00838	1	CrCbGaD
Ethosuximide—Paranoia—Galantamine—Alzheimer's disease	0.00824	0.0165	CcSEcCtD
Ethosuximide—Suicidal ideation—Galantamine—Alzheimer's disease	0.00801	0.016	CcSEcCtD
Ethosuximide—Tongue oedema—Donepezil—Alzheimer's disease	0.00776	0.0156	CcSEcCtD
Ethosuximide—Hirsutism—Donepezil—Alzheimer's disease	0.00749	0.015	CcSEcCtD
Ethosuximide—Libido increased—Donepezil—Alzheimer's disease	0.00715	0.0143	CcSEcCtD
Ethosuximide—Cerebration impaired—Memantine—Alzheimer's disease	0.00672	0.0135	CcSEcCtD
Ethosuximide—Upset stomach—Donepezil—Alzheimer's disease	0.00664	0.0133	CcSEcCtD
Ethosuximide—Cerebration impaired—Rivastigmine—Alzheimer's disease	0.00657	0.0132	CcSEcCtD
Ethosuximide—Libido increased—Memantine—Alzheimer's disease	0.00649	0.013	CcSEcCtD
Ethosuximide—Aggression—Galantamine—Alzheimer's disease	0.00639	0.0128	CcSEcCtD
Ethosuximide—Paranoia—Donepezil—Alzheimer's disease	0.00638	0.0128	CcSEcCtD
Ethosuximide—Libido increased—Rivastigmine—Alzheimer's disease	0.00635	0.0127	CcSEcCtD
Ethosuximide—Tongue disorder—Donepezil—Alzheimer's disease	0.00598	0.012	CcSEcCtD
Ethosuximide—Paranoia—Memantine—Alzheimer's disease	0.0058	0.0116	CcSEcCtD
Ethosuximide—Paranoia—Rivastigmine—Alzheimer's disease	0.00567	0.0114	CcSEcCtD
Ethosuximide—Suicidal ideation—Memantine—Alzheimer's disease	0.00563	0.0113	CcSEcCtD
Ethosuximide—Hiccups—Galantamine—Alzheimer's disease	0.00562	0.0112	CcSEcCtD
Ethosuximide—Suicidal ideation—Rivastigmine—Alzheimer's disease	0.00551	0.011	CcSEcCtD
Ethosuximide—Vaginal haemorrhage—Memantine—Alzheimer's disease	0.00534	0.0107	CcSEcCtD
Ethosuximide—Vaginal haemorrhage—Rivastigmine—Alzheimer's disease	0.00522	0.0105	CcSEcCtD
Ethosuximide—Rash erythematous—Memantine—Alzheimer's disease	0.00516	0.0103	CcSEcCtD
Ethosuximide—Rash erythematous—Rivastigmine—Alzheimer's disease	0.00505	0.0101	CcSEcCtD
Ethosuximide—Aggression—Donepezil—Alzheimer's disease	0.00495	0.00992	CcSEcCtD
Ethosuximide—Hyperkinesia—Galantamine—Alzheimer's disease	0.0049	0.00981	CcSEcCtD
Ethosuximide—Disturbance in attention—Memantine—Alzheimer's disease	0.00456	0.00914	CcSEcCtD
Ethosuximide—Aggression—Memantine—Alzheimer's disease	0.0045	0.00901	CcSEcCtD
Ethosuximide—Disturbance in attention—Rivastigmine—Alzheimer's disease	0.00446	0.00894	CcSEcCtD
Ethosuximide—Aggression—Rivastigmine—Alzheimer's disease	0.0044	0.00881	CcSEcCtD
Ethosuximide—Lethargy—Galantamine—Alzheimer's disease	0.00416	0.00833	CcSEcCtD
Ethosuximide—Disturbance in sexual arousal—Galantamine—Alzheimer's disease	0.00404	0.0081	CcSEcCtD
Ethosuximide—Hiccups—Rivastigmine—Alzheimer's disease	0.00387	0.00774	CcSEcCtD
Ethosuximide—Ataxia—Galantamine—Alzheimer's disease	0.00383	0.00768	CcSEcCtD
Ethosuximide—Euphoric mood—Donepezil—Alzheimer's disease	0.00374	0.00749	CcSEcCtD
Ethosuximide—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00372	0.00746	CcSEcCtD
Ethosuximide—Hyperkinesia—Memantine—Alzheimer's disease	0.00345	0.0069	CcSEcCtD
Ethosuximide—Mental disability—Memantine—Alzheimer's disease	0.00343	0.00687	CcSEcCtD
Ethosuximide—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00338	0.00677	CcSEcCtD
Ethosuximide—Hyperkinesia—Rivastigmine—Alzheimer's disease	0.00337	0.00675	CcSEcCtD
Ethosuximide—Mental disability—Rivastigmine—Alzheimer's disease	0.00335	0.00672	CcSEcCtD
Ethosuximide—Sleep disorder—Memantine—Alzheimer's disease	0.00331	0.00664	CcSEcCtD
Ethosuximide—Sleep disorder—Rivastigmine—Alzheimer's disease	0.00324	0.00649	CcSEcCtD
Ethosuximide—Weight decreased—Galantamine—Alzheimer's disease	0.00319	0.00638	CcSEcCtD
Ethosuximide—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.00313	0.00628	CcSEcCtD
Ethosuximide—Psychotic disorder—Donepezil—Alzheimer's disease	0.00308	0.00618	CcSEcCtD
Ethosuximide—Irritability—Donepezil—Alzheimer's disease	0.00301	0.00604	CcSEcCtD
Ethosuximide—Haematuria—Galantamine—Alzheimer's disease	0.00299	0.006	CcSEcCtD
Ethosuximide—Ataxia—Donepezil—Alzheimer's disease	0.00297	0.00595	CcSEcCtD
Ethosuximide—Lethargy—Memantine—Alzheimer's disease	0.00293	0.00586	CcSEcCtD
Ethosuximide—Abdominal pain upper—Donepezil—Alzheimer's disease	0.00288	0.00578	CcSEcCtD
Ethosuximide—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.00285	0.0057	CcSEcCtD
Ethosuximide—Cramp muscle—Donepezil—Alzheimer's disease	0.00284	0.0057	CcSEcCtD
Ethosuximide—Psychotic disorder—Memantine—Alzheimer's disease	0.0028	0.00561	CcSEcCtD
Ethosuximide—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00278	0.00558	CcSEcCtD
Ethosuximide—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00278	0.00558	CcSEcCtD
Ethosuximide—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00277	0.00555	CcSEcCtD
Ethosuximide—Urethral disorder—Galantamine—Alzheimer's disease	0.00276	0.00554	CcSEcCtD
Ethosuximide—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00274	0.00549	CcSEcCtD
Ethosuximide—Irritability—Memantine—Alzheimer's disease	0.00274	0.00548	CcSEcCtD
Ethosuximide—Eosinophilia—Donepezil—Alzheimer's disease	0.0027	0.00542	CcSEcCtD
Ethosuximide—Ataxia—Memantine—Alzheimer's disease	0.0027	0.0054	CcSEcCtD
Ethosuximide—Ataxia—Rivastigmine—Alzheimer's disease	0.00264	0.00529	CcSEcCtD
Ethosuximide—Eye disorder—Galantamine—Alzheimer's disease	0.00264	0.00528	CcSEcCtD
Ethosuximide—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00262	0.00524	CcSEcCtD
Ethosuximide—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.00256	0.00513	CcSEcCtD
Ethosuximide—Immune system disorder—Galantamine—Alzheimer's disease	0.00255	0.0051	CcSEcCtD
Ethosuximide—Breast disorder—Rivastigmine—Alzheimer's disease	0.00254	0.00508	CcSEcCtD
Ethosuximide—Cramp muscle—Rivastigmine—Alzheimer's disease	0.00253	0.00506	CcSEcCtD
Ethosuximide—Mental disorder—Galantamine—Alzheimer's disease	0.00247	0.00495	CcSEcCtD
Ethosuximide—Weight decreased—Donepezil—Alzheimer's disease	0.00247	0.00495	CcSEcCtD
Ethosuximide—Malnutrition—Galantamine—Alzheimer's disease	0.00245	0.00492	CcSEcCtD
Ethosuximide—Muscle spasms—Galantamine—Alzheimer's disease	0.00236	0.00473	CcSEcCtD
Ethosuximide—Pancytopenia—Memantine—Alzheimer's disease	0.00235	0.00472	CcSEcCtD
Ethosuximide—Haematuria—Donepezil—Alzheimer's disease	0.00232	0.00465	CcSEcCtD
Ethosuximide—Agitation—Galantamine—Alzheimer's disease	0.00226	0.00452	CcSEcCtD
Ethosuximide—Weight decreased—Memantine—Alzheimer's disease	0.00224	0.00449	CcSEcCtD
Ethosuximide—Weight decreased—Rivastigmine—Alzheimer's disease	0.00219	0.0044	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00219	0.00439	CcSEcCtD
Ethosuximide—Drowsiness—Rivastigmine—Alzheimer's disease	0.00216	0.00433	CcSEcCtD
Ethosuximide—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00216	0.00432	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.00214	0.00429	CcSEcCtD
Ethosuximide—Urethral disorder—Donepezil—Alzheimer's disease	0.00214	0.00429	CcSEcCtD
Ethosuximide—Haematuria—Memantine—Alzheimer's disease	0.00211	0.00422	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00208	0.00416	CcSEcCtD
Ethosuximide—Agranulocytosis—Memantine—Alzheimer's disease	0.00206	0.00413	CcSEcCtD
Ethosuximide—Haematuria—Rivastigmine—Alzheimer's disease	0.00206	0.00413	CcSEcCtD
Ethosuximide—Nervous system disorder—Galantamine—Alzheimer's disease	0.00196	0.00394	CcSEcCtD
Ethosuximide—Urinary tract disorder—Memantine—Alzheimer's disease	0.00196	0.00393	CcSEcCtD
Ethosuximide—Connective tissue disorder—Memantine—Alzheimer's disease	0.00195	0.00391	CcSEcCtD
Ethosuximide—Skin disorder—Galantamine—Alzheimer's disease	0.00195	0.0039	CcSEcCtD
Ethosuximide—Urethral disorder—Memantine—Alzheimer's disease	0.00194	0.0039	CcSEcCtD
Ethosuximide—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00192	0.00384	CcSEcCtD
Ethosuximide—Mental disorder—Donepezil—Alzheimer's disease	0.00191	0.00384	CcSEcCtD
Ethosuximide—Anorexia—Galantamine—Alzheimer's disease	0.00191	0.00383	CcSEcCtD
Ethosuximide—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00191	0.00382	CcSEcCtD
Ethosuximide—Urethral disorder—Rivastigmine—Alzheimer's disease	0.0019	0.00381	CcSEcCtD
Ethosuximide—Malnutrition—Donepezil—Alzheimer's disease	0.0019	0.00381	CcSEcCtD
Ethosuximide—Erythema multiforme—Memantine—Alzheimer's disease	0.00188	0.00376	CcSEcCtD
Ethosuximide—Eye disorder—Memantine—Alzheimer's disease	0.00185	0.00371	CcSEcCtD
Ethosuximide—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00184	0.00368	CcSEcCtD
Ethosuximide—Muscle spasms—Donepezil—Alzheimer's disease	0.00183	0.00366	CcSEcCtD
Ethosuximide—Eye disorder—Rivastigmine—Alzheimer's disease	0.00181	0.00363	CcSEcCtD
Ethosuximide—Immune system disorder—Memantine—Alzheimer's disease	0.00179	0.00359	CcSEcCtD
Ethosuximide—Mediastinal disorder—Memantine—Alzheimer's disease	0.00179	0.00358	CcSEcCtD
Ethosuximide—Somnolence—Galantamine—Alzheimer's disease	0.00178	0.00357	CcSEcCtD
Ethosuximide—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00175	0.0035	CcSEcCtD
Ethosuximide—Agitation—Donepezil—Alzheimer's disease	0.00175	0.0035	CcSEcCtD
Ethosuximide—Decreased appetite—Galantamine—Alzheimer's disease	0.00174	0.00349	CcSEcCtD
Ethosuximide—Mental disorder—Memantine—Alzheimer's disease	0.00174	0.00348	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00173	0.00346	CcSEcCtD
Ethosuximide—Malnutrition—Memantine—Alzheimer's disease	0.00173	0.00346	CcSEcCtD
Ethosuximide—Fatigue—Galantamine—Alzheimer's disease	0.00173	0.00346	CcSEcCtD
Ethosuximide—Mental disorder—Rivastigmine—Alzheimer's disease	0.0017	0.00341	CcSEcCtD
Ethosuximide—Malnutrition—Rivastigmine—Alzheimer's disease	0.00169	0.00338	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00164	0.00328	CcSEcCtD
Ethosuximide—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00162	0.00325	CcSEcCtD
Ethosuximide—Agitation—Memantine—Alzheimer's disease	0.00159	0.00318	CcSEcCtD
Ethosuximide—Abdominal pain—Galantamine—Alzheimer's disease	0.00158	0.00317	CcSEcCtD
Ethosuximide—Agitation—Rivastigmine—Alzheimer's disease	0.00155	0.00311	CcSEcCtD
Ethosuximide—Leukopenia—Memantine—Alzheimer's disease	0.00155	0.0031	CcSEcCtD
Ethosuximide—Nervous system disorder—Donepezil—Alzheimer's disease	0.00152	0.00305	CcSEcCtD
Ethosuximide—Anorexia—Donepezil—Alzheimer's disease	0.00148	0.00296	CcSEcCtD
Ethosuximide—Hypersensitivity—Galantamine—Alzheimer's disease	0.00148	0.00296	CcSEcCtD
Ethosuximide—Asthenia—Galantamine—Alzheimer's disease	0.00144	0.00288	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00143	0.00286	CcSEcCtD
Ethosuximide—Nervous system disorder—Memantine—Alzheimer's disease	0.00138	0.00277	CcSEcCtD
Ethosuximide—Somnolence—Donepezil—Alzheimer's disease	0.00138	0.00276	CcSEcCtD
Ethosuximide—Diarrhoea—Galantamine—Alzheimer's disease	0.00137	0.00275	CcSEcCtD
Ethosuximide—Skin disorder—Memantine—Alzheimer's disease	0.00137	0.00274	CcSEcCtD
Ethosuximide—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00135	0.00271	CcSEcCtD
Ethosuximide—Decreased appetite—Donepezil—Alzheimer's disease	0.00135	0.0027	CcSEcCtD
Ethosuximide—Anorexia—Memantine—Alzheimer's disease	0.00134	0.00269	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00134	0.00269	CcSEcCtD
Ethosuximide—Skin disorder—Rivastigmine—Alzheimer's disease	0.00134	0.00268	CcSEcCtD
Ethosuximide—Fatigue—Donepezil—Alzheimer's disease	0.00134	0.00268	CcSEcCtD
Ethosuximide—Dizziness—Galantamine—Alzheimer's disease	0.00132	0.00265	CcSEcCtD
Ethosuximide—Anorexia—Rivastigmine—Alzheimer's disease	0.00131	0.00263	CcSEcCtD
Ethosuximide—Vomiting—Galantamine—Alzheimer's disease	0.00127	0.00255	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00127	0.00254	CcSEcCtD
Ethosuximide—Rash—Galantamine—Alzheimer's disease	0.00126	0.00253	CcSEcCtD
Ethosuximide—Dermatitis—Galantamine—Alzheimer's disease	0.00126	0.00253	CcSEcCtD
Ethosuximide—Headache—Galantamine—Alzheimer's disease	0.00125	0.00251	CcSEcCtD
Ethosuximide—Somnolence—Memantine—Alzheimer's disease	0.00125	0.00251	CcSEcCtD
Ethosuximide—Urticaria—Donepezil—Alzheimer's disease	0.00123	0.00247	CcSEcCtD
Ethosuximide—Abdominal pain—Donepezil—Alzheimer's disease	0.00123	0.00246	CcSEcCtD
Ethosuximide—Somnolence—Rivastigmine—Alzheimer's disease	0.00123	0.00246	CcSEcCtD
Ethosuximide—Decreased appetite—Memantine—Alzheimer's disease	0.00123	0.00245	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00122	0.00244	CcSEcCtD
Ethosuximide—Fatigue—Memantine—Alzheimer's disease	0.00122	0.00243	CcSEcCtD
Ethosuximide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.0012	0.0024	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00119	0.00239	CcSEcCtD
Ethosuximide—Nausea—Galantamine—Alzheimer's disease	0.00119	0.00238	CcSEcCtD
Ethosuximide—Fatigue—Rivastigmine—Alzheimer's disease	0.00119	0.00238	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00115	0.00231	CcSEcCtD
Ethosuximide—Hypersensitivity—Donepezil—Alzheimer's disease	0.00114	0.00229	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00113	0.00226	CcSEcCtD
Ethosuximide—Urticaria—Memantine—Alzheimer's disease	0.00112	0.00224	CcSEcCtD
Ethosuximide—Abdominal pain—Memantine—Alzheimer's disease	0.00111	0.00223	CcSEcCtD
Ethosuximide—Asthenia—Donepezil—Alzheimer's disease	0.00111	0.00223	CcSEcCtD
Ethosuximide—Urticaria—Rivastigmine—Alzheimer's disease	0.0011	0.00219	CcSEcCtD
Ethosuximide—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00109	0.00218	CcSEcCtD
Ethosuximide—Diarrhoea—Donepezil—Alzheimer's disease	0.00106	0.00213	CcSEcCtD
Ethosuximide—Hypersensitivity—Memantine—Alzheimer's disease	0.00104	0.00208	CcSEcCtD
Ethosuximide—Dizziness—Donepezil—Alzheimer's disease	0.00103	0.00206	CcSEcCtD
Ethosuximide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00102	0.00204	CcSEcCtD
Ethosuximide—Asthenia—Memantine—Alzheimer's disease	0.00101	0.00203	CcSEcCtD
Ethosuximide—Asthenia—Rivastigmine—Alzheimer's disease	0.000989	0.00198	CcSEcCtD
Ethosuximide—Vomiting—Donepezil—Alzheimer's disease	0.000987	0.00198	CcSEcCtD
Ethosuximide—Rash—Donepezil—Alzheimer's disease	0.000979	0.00196	CcSEcCtD
Ethosuximide—Dermatitis—Donepezil—Alzheimer's disease	0.000978	0.00196	CcSEcCtD
Ethosuximide—Headache—Donepezil—Alzheimer's disease	0.000973	0.00195	CcSEcCtD
Ethosuximide—Diarrhoea—Memantine—Alzheimer's disease	0.000964	0.00193	CcSEcCtD
Ethosuximide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000944	0.00189	CcSEcCtD
Ethosuximide—Dizziness—Memantine—Alzheimer's disease	0.000932	0.00187	CcSEcCtD
Ethosuximide—Nausea—Donepezil—Alzheimer's disease	0.000922	0.00185	CcSEcCtD
Ethosuximide—Dizziness—Rivastigmine—Alzheimer's disease	0.000912	0.00183	CcSEcCtD
Ethosuximide—Vomiting—Memantine—Alzheimer's disease	0.000896	0.0018	CcSEcCtD
Ethosuximide—Rash—Memantine—Alzheimer's disease	0.000889	0.00178	CcSEcCtD
Ethosuximide—Dermatitis—Memantine—Alzheimer's disease	0.000888	0.00178	CcSEcCtD
Ethosuximide—Headache—Memantine—Alzheimer's disease	0.000883	0.00177	CcSEcCtD
Ethosuximide—Vomiting—Rivastigmine—Alzheimer's disease	0.000877	0.00176	CcSEcCtD
Ethosuximide—Rash—Rivastigmine—Alzheimer's disease	0.000869	0.00174	CcSEcCtD
Ethosuximide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000869	0.00174	CcSEcCtD
Ethosuximide—Headache—Rivastigmine—Alzheimer's disease	0.000864	0.00173	CcSEcCtD
Ethosuximide—Nausea—Memantine—Alzheimer's disease	0.000837	0.00168	CcSEcCtD
Ethosuximide—Nausea—Rivastigmine—Alzheimer's disease	0.000819	0.00164	CcSEcCtD
Ethosuximide—CACNA1G—Axon guidance—PRNP—Alzheimer's disease	0.000621	0.00467	CbGpPWpGaD
Ethosuximide—CYP3A5—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000614	0.00461	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—PSEN2—Alzheimer's disease	0.000601	0.00452	CbGpPWpGaD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000568	0.00427	CbGpPWpGaD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000557	0.00419	CbGpPWpGaD
Ethosuximide—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000556	0.00418	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—PSENEN—Alzheimer's disease	0.00055	0.00413	CbGpPWpGaD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000543	0.00408	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—APH1A—Alzheimer's disease	0.000542	0.00408	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000542	0.00407	CbGpPWpGaD
Ethosuximide—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000535	0.00402	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—NCSTN—Alzheimer's disease	0.000528	0.00397	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000521	0.00392	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000514	0.00386	CbGpPWpGaD
Ethosuximide—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000498	0.00374	CbGpPWpGaD
Ethosuximide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000497	0.00373	CbGpPWpGaD
Ethosuximide—CYP2E1—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000491	0.00369	CbGpPWpGaD
Ethosuximide—CYP3A5—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.00049	0.00369	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP46A1—Alzheimer's disease	0.000483	0.00363	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP46A1—Alzheimer's disease	0.000482	0.00363	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000477	0.00358	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000476	0.00358	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—DLG4—Alzheimer's disease	0.000459	0.00345	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—GRIN2B—Alzheimer's disease	0.000449	0.00338	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—PRNP—Alzheimer's disease	0.000443	0.00333	CbGpPWpGaD
Ethosuximide—CYP2E1—Vitamin A and Carotenoid Metabolism—LPL—Alzheimer's disease	0.000442	0.00332	CbGpPWpGaD
Ethosuximide—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000433	0.00326	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—PSEN2—Alzheimer's disease	0.000429	0.00323	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—DHCR24—Alzheimer's disease	0.000424	0.00319	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000422	0.00317	CbGpPWpGaD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000411	0.00309	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.00041	0.00309	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—ADAM10—Alzheimer's disease	0.000405	0.00304	CbGpPWpGaD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000403	0.00303	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000403	0.00303	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—MAOB—Alzheimer's disease	0.000398	0.00299	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—IAPP—Alzheimer's disease	0.000393	0.00295	CbGpPWpGaD
Ethosuximide—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000389	0.00293	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000384	0.00289	CbGpPWpGaD
Ethosuximide—CACNA1G—NCAM signaling for neurite out-growth—IL6—Alzheimer's disease	0.000369	0.00277	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CA4—Alzheimer's disease	0.000361	0.00271	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GAPDHS—Alzheimer's disease	0.000339	0.00255	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—DLG4—Alzheimer's disease	0.000328	0.00247	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ATP5A1—Alzheimer's disease	0.000322	0.00242	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—GRIN2B—Alzheimer's disease	0.00032	0.00241	CbGpPWpGaD
Ethosuximide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000315	0.00237	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PLD3—Alzheimer's disease	0.000307	0.00231	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—PTGS1—Alzheimer's disease	0.000302	0.00227	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—CYP2D6—Alzheimer's disease	0.000296	0.00222	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—HSD17B10—Alzheimer's disease	0.000294	0.00221	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000292	0.00219	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—ADAM10—Alzheimer's disease	0.000289	0.00217	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—MAOB—Alzheimer's disease	0.000288	0.00217	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—MAOB—Alzheimer's disease	0.000288	0.00216	CbGpPWpGaD
Ethosuximide—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000285	0.00215	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP46A1—Alzheimer's disease	0.000283	0.00213	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ND1—Alzheimer's disease	0.000274	0.00206	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—PPARGC1A—Alzheimer's disease	0.000265	0.00199	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000252	0.00189	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—GSK3B—Alzheimer's disease	0.000245	0.00184	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—CREB1—Alzheimer's disease	0.000243	0.00183	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—LPL—Alzheimer's disease	0.000241	0.00181	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MEF2C—Alzheimer's disease	0.000239	0.0018	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000231	0.00174	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000228	0.00171	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.000224	0.00169	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000221	0.00166	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—PTGS1—Alzheimer's disease	0.000218	0.00164	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—PTGS1—Alzheimer's disease	0.000218	0.00164	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP2D6—Alzheimer's disease	0.000214	0.00161	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP2D6—Alzheimer's disease	0.000214	0.00161	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000211	0.00159	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000211	0.00159	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—LEP—Alzheimer's disease	0.000202	0.00152	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000191	0.00144	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000187	0.00141	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—NOTCH1—Alzheimer's disease	0.000186	0.0014	CbGpPWpGaD
Ethosuximide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000181	0.00136	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CHAT—Alzheimer's disease	0.000176	0.00133	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—TPI1—Alzheimer's disease	0.000176	0.00133	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—PPARG—Alzheimer's disease	0.000176	0.00132	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—GSK3B—Alzheimer's disease	0.000175	0.00132	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—CREB1—Alzheimer's disease	0.000174	0.00131	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—INS—Alzheimer's disease	0.000173	0.0013	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—DHCR24—Alzheimer's disease	0.000171	0.00129	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—MAOB—Alzheimer's disease	0.000169	0.00127	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GAPDH—Alzheimer's disease	0.000163	0.00122	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—A2M—Alzheimer's disease	0.000157	0.00118	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—VEGFA—Alzheimer's disease	0.000153	0.00115	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CA4—Alzheimer's disease	0.000145	0.00109	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GAPDHS—Alzheimer's disease	0.000137	0.00103	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ACHE—Alzheimer's disease	0.000137	0.00103	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—INPP5D—Alzheimer's disease	0.000135	0.00102	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	0.000134	0.00101	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ATP5A1—Alzheimer's disease	0.00013	0.000974	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTGS1—Alzheimer's disease	0.000128	0.000963	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ENO1—Alzheimer's disease	0.000128	0.000963	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP2D6—Alzheimer's disease	0.000126	0.000945	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—DHCR24—Alzheimer's disease	0.000124	0.000931	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PLD3—Alzheimer's disease	0.000124	0.00093	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—DHCR24—Alzheimer's disease	0.000124	0.000929	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—BCHE—Alzheimer's disease	0.000119	0.000895	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HSD17B10—Alzheimer's disease	0.000119	0.000891	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP46A1—Alzheimer's disease	0.000114	0.000858	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PLCB1—Alzheimer's disease	0.000112	0.000845	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ND1—Alzheimer's disease	0.00011	0.000829	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—VEGFA—Alzheimer's disease	0.000109	0.00082	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ABCA1—Alzheimer's disease	0.000109	0.000819	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—IL6—Alzheimer's disease	0.000106	0.000795	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CA4—Alzheimer's disease	0.000105	0.000792	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CA4—Alzheimer's disease	0.000105	0.00079	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	0.000101	0.000762	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—TGFB1—Alzheimer's disease	0.0001	0.000753	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	9.94e-05	0.000748	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GAPDHS—Alzheimer's disease	9.9e-05	0.000745	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GAPDHS—Alzheimer's disease	9.88e-05	0.000743	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	9.8e-05	0.000737	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ATP5A1—Alzheimer's disease	9.39e-05	0.000706	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PPARGC1A—Alzheimer's disease	9.39e-05	0.000706	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ATP5A1—Alzheimer's disease	9.37e-05	0.000704	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—TNF—Alzheimer's disease	9.35e-05	0.000703	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—HMOX1—Alzheimer's disease	9.34e-05	0.000703	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PLD3—Alzheimer's disease	8.95e-05	0.000673	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PLD3—Alzheimer's disease	8.93e-05	0.000672	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HSD17B10—Alzheimer's disease	8.58e-05	0.000646	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HSD17B10—Alzheimer's disease	8.57e-05	0.000644	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—LPL—Alzheimer's disease	8.54e-05	0.000643	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP46A1—Alzheimer's disease	8.26e-05	0.000621	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP46A1—Alzheimer's disease	8.25e-05	0.00062	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ND1—Alzheimer's disease	7.98e-05	0.0006	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ND1—Alzheimer's disease	7.96e-05	0.000599	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—MTHFR—Alzheimer's disease	7.69e-05	0.000579	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—IL6—Alzheimer's disease	7.54e-05	0.000567	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CALM1—Alzheimer's disease	7.19e-05	0.000541	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—APOE—Alzheimer's disease	7.16e-05	0.000539	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CHAT—Alzheimer's disease	7.1e-05	0.000534	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—TPI1—Alzheimer's disease	7.1e-05	0.000534	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CAV1—Alzheimer's disease	7.1e-05	0.000534	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—AKT1—Alzheimer's disease	6.96e-05	0.000523	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—MAOB—Alzheimer's disease	6.81e-05	0.000512	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GAPDH—Alzheimer's disease	6.55e-05	0.000493	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—A2M—Alzheimer's disease	6.33e-05	0.000476	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PPARG—Alzheimer's disease	6.24e-05	0.000469	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—INS—Alzheimer's disease	6.12e-05	0.00046	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	5.75e-05	0.000432	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ACHE—Alzheimer's disease	5.5e-05	0.000414	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—INPP5D—Alzheimer's disease	5.44e-05	0.000409	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—NOS3—Alzheimer's disease	5.37e-05	0.000404	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ENO1—Alzheimer's disease	5.16e-05	0.000388	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTGS1—Alzheimer's disease	5.16e-05	0.000388	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—TPI1—Alzheimer's disease	5.14e-05	0.000387	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CHAT—Alzheimer's disease	5.14e-05	0.000387	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—TPI1—Alzheimer's disease	5.13e-05	0.000386	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CHAT—Alzheimer's disease	5.13e-05	0.000386	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2D6—Alzheimer's disease	5.06e-05	0.00038	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MAOB—Alzheimer's disease	4.93e-05	0.000371	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MAOB—Alzheimer's disease	4.92e-05	0.00037	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTGS2—Alzheimer's disease	4.91e-05	0.000369	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CA4—Alzheimer's disease	4.89e-05	0.000367	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—BCHE—Alzheimer's disease	4.8e-05	0.000361	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GAPDH—Alzheimer's disease	4.75e-05	0.000357	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	4.74e-05	0.000356	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	4.59e-05	0.000345	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—A2M—Alzheimer's disease	4.58e-05	0.000345	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—A2M—Alzheimer's disease	4.57e-05	0.000344	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PLCB1—Alzheimer's disease	4.52e-05	0.00034	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ABCA1—Alzheimer's disease	4.39e-05	0.00033	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	4.35e-05	0.000327	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PLD3—Alzheimer's disease	4.15e-05	0.000312	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ACHE—Alzheimer's disease	3.99e-05	0.0003	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3.98e-05	0.0003	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ACHE—Alzheimer's disease	3.98e-05	0.000299	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—INPP5D—Alzheimer's disease	3.94e-05	0.000296	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	3.93e-05	0.000296	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.83e-05	0.000288	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PPARGC1A—Alzheimer's disease	3.78e-05	0.000284	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HMOX1—Alzheimer's disease	3.76e-05	0.000283	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	3.74e-05	0.000281	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ENO1—Alzheimer's disease	3.74e-05	0.000281	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ENO1—Alzheimer's disease	3.73e-05	0.00028	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	3.73e-05	0.00028	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.7e-05	0.000278	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	3.66e-05	0.000276	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	3.66e-05	0.000275	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—BCHE—Alzheimer's disease	3.47e-05	0.000261	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—BCHE—Alzheimer's disease	3.47e-05	0.000261	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—LPL—Alzheimer's disease	3.44e-05	0.000259	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	3.28e-05	0.000247	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	3.27e-05	0.000246	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	3.18e-05	0.000239	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	3.17e-05	0.000238	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	3.1e-05	0.000233	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CALM1—Alzheimer's disease	2.89e-05	0.000218	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—APOE—Alzheimer's disease	2.88e-05	0.000217	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CAV1—Alzheimer's disease	2.86e-05	0.000215	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	2.74e-05	0.000206	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	2.73e-05	0.000206	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	2.73e-05	0.000205	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	2.72e-05	0.000205	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PPARG—Alzheimer's disease	2.51e-05	0.000189	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—LPL—Alzheimer's disease	2.49e-05	0.000187	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—LPL—Alzheimer's disease	2.49e-05	0.000187	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—AKT1—Alzheimer's disease	2.47e-05	0.000186	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—INS—Alzheimer's disease	2.46e-05	0.000185	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.39e-05	0.000179	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.39e-05	0.000179	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.29e-05	0.000172	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	2.24e-05	0.000169	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	2.24e-05	0.000168	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.2e-05	0.000166	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NOS3—Alzheimer's disease	2.16e-05	0.000163	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.13e-05	0.00016	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CALM1—Alzheimer's disease	2.1e-05	0.000158	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CALM1—Alzheimer's disease	2.09e-05	0.000157	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—APOE—Alzheimer's disease	2.09e-05	0.000157	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—APOE—Alzheimer's disease	2.09e-05	0.000157	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CAV1—Alzheimer's disease	2.07e-05	0.000156	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CAV1—Alzheimer's disease	2.07e-05	0.000155	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	1.98e-05	0.000149	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.85e-05	0.000139	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.83e-05	0.000138	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PPARG—Alzheimer's disease	1.82e-05	0.000137	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PPARG—Alzheimer's disease	1.82e-05	0.000137	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—INS—Alzheimer's disease	1.79e-05	0.000134	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—INS—Alzheimer's disease	1.78e-05	0.000134	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.73e-05	0.00013	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.73e-05	0.00013	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.7e-05	0.000128	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.61e-05	0.000121	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NOS3—Alzheimer's disease	1.57e-05	0.000118	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.56e-05	0.000117	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.52e-05	0.000114	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.47e-05	0.000111	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	1.43e-05	0.000108	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.43e-05	0.000107	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.27e-05	9.55e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.26e-05	9.51e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.16e-05	8.7e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.04e-05	7.83e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AKT1—Alzheimer's disease	9.93e-06	7.47e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CALM1—Alzheimer's disease	9.73e-06	7.32e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—APOE—Alzheimer's disease	9.69e-06	7.29e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CAV1—Alzheimer's disease	9.61e-06	7.22e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.44e-06	6.35e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—INS—Alzheimer's disease	8.28e-06	6.23e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.26e-06	5.46e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AKT1—Alzheimer's disease	7.2e-06	5.41e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AKT1—Alzheimer's disease	7.18e-06	5.4e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.64e-06	5e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.34e-06	2.51e-05	CbGpPWpGaD
